Flavone Acetic Acid (NSC 347512)
Executive Summary
National Cancer Institute has received an IND for the compound, which has shown antitumor activity in animals. Phase I clinicals are expected to begin shortly.
National Cancer Institute has received an IND for the compound,
which has shown antitumor activity in animals. Phase I
clinicals are expected to begin shortly. |